• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Transl Med . A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples

tetano

Editor, Senior Moderator
Sci Transl Med


. 2020 Jul 27;eabc7075.
doi: 10.1126/scitranslmed.abc7075. Online ahead of print.
A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples


Viet Loan Dao Thi[SUP] 1 2 [/SUP], Konrad Herbst[SUP] #[/SUP][SUP] 3 [/SUP], Kathleen Boerner[SUP] #[/SUP][SUP] 2 4 [/SUP], Matthias Meurer[SUP] #[/SUP][SUP] 3 [/SUP], Lukas Pm Kremer[SUP] 3 5 6 [/SUP], Daniel Kirrmaier[SUP] 3 5 [/SUP], Andrew Freistaedter[SUP] 7 2 [/SUP], Dimitrios Papagiannidis[SUP] 3 [/SUP], Carla Galmozzi[SUP] 3 6 [/SUP], Megan L Stanifer[SUP] 2 [/SUP], Steeve Boulant[SUP] 2 5 [/SUP], Steffen Klein[SUP] 7 2 [/SUP], Petr Chlanda[SUP] 7 2 [/SUP], Dina Khalid[SUP] 2 [/SUP], Isabel Barreto Miranda[SUP] 2 [/SUP], Paul Schnitzler[SUP] 2 [/SUP], Hans-Georg Kr?usslich[SUP] 2 4 [/SUP], Michael Knop[SUP] 8 5 6 [/SUP], Simon Anders[SUP] 8 [/SUP]



Affiliations

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus is a major public health challenge. Rapid tests for detecting existing SARS-CoV-2 infections and assessing virus spread are critical. Approaches to detect viral RNA based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) have potential as simple, scalable, and broadly applicable testing methods. Compared to RT-qPCR-based methods, RT-LAMP assays require incubation at a constant temperature, thus eliminating the need for sophisticated instrumentation. Here, we tested a two-color RT-LAMP assay protocol for detecting SARS-CoV-2 viral RNA using a primer set specific for the N gene. We tested our RT-LAMP assay on surplus RNA samples isolated from 768 pharyngeal swab specimens collected from individuals being tested for COVID-19. We determined the sensitivity and specificity of the RT-LAMP assay for detecting SARS-CoV-2 viral RNA. Compared to an RT-qPCR assay using a sensitive primer set, we found that the RT-LAMP assay reliably detected SARS-CoV-2 RNA with an RT-qPCR cycle threshold (CT) number of up to 30, with a sensitivity of 97.5% and a specificity of 99.7%. We also developed a swab-to-RT-LAMP assay that did not require a prior RNA isolation step, which retained excellent specificity (99.5%) but showed lower sensitivity (86% for CT<30) than the RT-LAMP assay. In addition, we developed a multiplexed sequencing protocol (LAMP-sequencing) as a diagnostic validation procedure to detect and record the outcome of RT-LAMP reactions.
 
Back
Top Bottom